Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4

被引:54
作者
Viegas, LR
Vicent, GP
Barañao, JL
Beato, M
Pecci, A
机构
[1] Ctr Regulacio Genom, E-08003 Barcelona, Spain
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, RA-1428 Buenos Aires, DF, Argentina
关键词
D O I
10.1074/jbc.M312402200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-X exists in at least five different isoforms with complex effects on programmed cell death. Glucocorticoids and progestins control bcl-X expression and influence the ratio between bcl-X-L ( antiapoptotic isoform) and bcl-X-S (proapoptotic isoform) in different tissues. The 5'-UTR region of the mouse bcl-X gene contains at least five different promoters, which exhibit a tissue-specific pattern of promoter usage. Several mRNAs with different 5'-leading exons can be generated upon promoter activation. Here we explore the potential of the various bcl-X gene promoters to be regulated by glucocorticoids or progestins. We found that the region located immediately upstream of promoter 4 (P4) contains two hormone response element (HRE)-like sequences at positions - 3040 ( HRE I) and - 3001 ( HRE II) relative to the translation initiation codon. These HRE-like sequences confer hormone responsiveness to a core promoter and bind glucocorticoid or progesterone receptors in vitro. Point mutations of both HREs that prevent steroid receptor binding also eliminate hormonal inducibility. In cells treated with glucocorticoids, the hormone receptor is recruited to the P4 region containing the HREs. Analysis of the products of the endogenous bcl-X in epithelial mammary cells showed that only transcripts originating from P4 increased upon hormone treatment. This observation correlates with the induction of the bcl-X-L mRNA, suggesting that P4 is one of the bcl-X promoters responsible for the generation of this antiapoptotic isoform.
引用
收藏
页码:9831 / 9839
页数:9
相关论文
共 30 条
[11]   Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL [J].
Gascoyne, DM ;
Kypta, RM ;
Vivanco, MDM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :18022-18029
[12]   GLUCOCORTICOID RECEPTOR MUTANTS THAT ARE CONSTITUTIVE ACTIVATORS OF TRANSCRIPTIONAL ENHANCEMENT [J].
GODOWSKI, PJ ;
RUSCONI, S ;
MIESFELD, R ;
YAMAMOTO, KR .
NATURE, 1987, 325 (6102) :365-368
[13]   Bax and Bcl-x(S) are induced at the onset of apoptosis in involuting mammary epithelial cells [J].
Heermeier, K ;
Benedict, M ;
Li, ML ;
Furth, P ;
Nunez, G ;
Henninghausen, L .
MECHANISMS OF DEVELOPMENT, 1996, 56 (1-2) :197-207
[14]  
KASTNER P, 1990, J BIOL CHEM, V265, P12163
[15]   ESTABLISHMENT AND CHARACTERIZATION OF A CELL-LINE OF HUMAN-BREAST CARCINOMA ORIGIN [J].
KEYDAR, I ;
CHEN, L ;
KARBY, S ;
WEISS, FR ;
DELAREA, J ;
RADU, M ;
CHAITCIK, S ;
BRENNER, HJ .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (05) :659-670
[16]  
KRAJEWSKI S, 1994, AM J PATHOL, V145, P515
[17]   STRUCTURAL DETERMINANTS OF A GLUCOCORTICOID RECEPTOR RECOGNITION ELEMENT [J].
NORDEEN, SK ;
SUH, BJ ;
KUHNEL, B ;
HUTCHISON, CA .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1866-1873
[18]   Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-X-L to bcl-X-S [J].
Pecci, A ;
Scholz, A ;
Pelster, D ;
Beato, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :11791-11798
[19]   Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene [J].
Pecci, A ;
Viegas, LR ;
Barañao, JL ;
Beato, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21062-21069
[20]   MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data [J].
Quandt, K ;
Frech, K ;
Karas, H ;
Wingender, E ;
Werner, T .
NUCLEIC ACIDS RESEARCH, 1995, 23 (23) :4878-4884